Gts Securities LLC Dynavax Technologies Corp Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$11.7 - $14.98 $286,813 - $367,219
24,514 Added 158.0%
40,029 $496,000
Q4 2023

Feb 14, 2024
SELL
$13.09 - $14.98 $80,791 - $92,456
-6,172 Reduced 28.46%
15,515 $216,000
Q3 2023

Nov 15, 2023
BUY
$12.64 - $14.99 $101,789 - $120,714
8,053 Added 59.07%
21,687 $320,000
Q2 2023

Aug 15, 2023
BUY
$9.85 - $13.17 $134,294 - $179,559
13,634 New
13,634 $176 Million

Others Institutions Holding DVAX

# of Institutions
276
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email